Shares

2 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q4 2020

Feb 09, 2021

SELL
$79.67 - $173.23 $980,897 - $2.13 Million
-12,312 Closed
0 $0
Q3 2020

Nov 12, 2020

BUY
$78.5 - $100.64 $966,492 - $1.24 Million
12,312 New
12,312 $1.03 Million

Others Institutions Holding CRSP

About CRISPR Therapeutics AG


  • Ticker CRSP
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 78,009,296
  • Market Cap $3.61B
  • Description
  • CRISPR Therapeutics AG, a gene editing company, focuses on developing gene-based medicines for serious diseases using its proprietary Clustered Regularly Interspaced Short Palindromic Repeats (CRISPR)/CRISPR-associated protein 9 (Cas9) platform. Its CRISPR/Cas9 is a gene editing technology that allows for precise directed changes to genomic DNA....
More about CRSP
Track This Portfolio

Track Trustees Of Princeton University Portfolio

Follow Trustees Of Princeton University and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Trustees Of Princeton University, based on Form 13F filings with the SEC.

News

Stay updated on Trustees Of Princeton University with notifications on news.